...Good afternoon, and welcome to Phathom Pharmaceuticals Virtual Investor Day. Thank you for joining us. My name is Todd Branning, and I'm Phathom's Chief Financial Officer. We have a very exciting and robust agenda today. As a housekeeping item before we begin the meeting, I want to make you aware that at the end of today's presentations, we will hold a Q&A session with our meeting presenters, including both our key opinion leaders and select members of Phathom's management team. You may submit questions at any time using the text box below your webcast window. We will try our best to answer as many questions as we can during the Q&A portion of the meeting. If you have questions after the meeting concludes, please send them to ir@phathompharma.com. As a reminder, matters covered in today's presentation, including the accompanying slides, include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of...
